Latest News

Korean AI firm Galux develops six novel therapeutic antibodies using innovative design methods
Read More
[Interview] DeepMind predicted proteins. A Korean startup says it's designing the future of antibodies.
Read More
Galux Unveils a Study in AI-Powered De Novo Antibody Design for Multiple Therapeutic Targets
Read More
Y-Biologics and Galux to co-develop AI-driven immune anticancer treatment
Read More
Galux Unveils Breakthrough AI Technology for Therapeutic Antibody Loop Design
Read More
Galux and LG Chem Initiate Joint Research on AI-Powered Cancer Drug Development
Read More
Galux to conduct joint research with LG Chem on cancer drug development
Read More
Showing 25-31 of 31 posts